Scott Wilson Curtis, Executive Vice-President at Antibe Therapeutics, holds 115.00K shares in Antibe Therapeutics (Ticker: ATBPF). Most recently, Scott Wilson Curtis Bought $15,000 shares of Antibe Therapeutics on Mar 08, 2024 for an estimated value of 7.80K.
What is the percentage of profitable transactions made by Scott Wilson Curtis?
The percentage of profitable transactions made by Scott Wilson Curtis is 50%.
What is the average return per transaction made by Scott Wilson Curtis?
The average return per transaction made by Scott Wilson Curtis is 22.10%.
What stocks does Scott Wilson Curtis hold?
Scott Wilson Curtis holds: ATBPF stocks.
What was Scott Wilson Curtis’s latest transaction?
Scott Wilson Curtis latest transaction was an Informative Buy of $7.80K.
What was Scott Wilson Curtis's most profitable transaction?
Scott Wilson Curtis’s most profitable transaction was an Informative Buy of ATBPF stock on June 26, 2017. The return on the trade was 478.10%.
What is Scott Wilson Curtis's role in Antibe Therapeutics?
Scott Wilson Curtis's role in Antibe Therapeutics is Executive Vice-President.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.